MET · Metlife Inc
Market Cap
$61.16B
Shares
635.48M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$96.51
Open$96.79
Day$96.41–97.44
52W close$67.70–99.95
Avg vol 30d3.7M
Short int11.3M · 1.8% float · 3.3d
Short vol58%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Research
our published analysis of this company
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very Low
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+18%
above
Price vs 50-day avg
+3%
above
RSI (14)
55
neutral
MACD trend
Negative
52-week position
89%
near high
Momentum
relative strength
1-month return
0%
trailing
6-month return
+36%
trailing
YTD return
+22%
this year
Relative strength
+23%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $93 › 200d $81 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +173 funds added
Insider flow
Distributing
Net -$1.7M over 90 days · 100% sells
Short interest
Rising
1.78% of float · ▲ +0.2% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,450 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+9%
Y/Y
EPS growth
−21%
Y/Y
Valuation
P/E 18.4
in line
Buyback
$3.0B
authorized
Balance sheet
$7.2B
net cash
Quant / Vol
risk profile
Volatility
24%
annualized · 1-yr
Max drawdown
−18%
past year
ATR
1.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 5, 2026
full-year 2026
Variable investment income (VII)
Initiated
$1.6B
2026
Direct expense ratio
12.1%
fiscal year ended March 31, 2026
Japan Economic Solvency Ratio (ESR)
Maintained
170% – 190%
May 6, 2026
170% – 190%
changed to
Aug 5, 2026
170% – 190%
Prior guidance
period ended
· from the 8-K filed Aug 6, 2025
Direct expense ratio, excluding total notable items related to d
· Annual target 2025
12.1%
Direct expense ratio
· 2025
12.1%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+18%
Bullish
Price vs 50-day avg
+3%
Bullish
RSI (14)
55
Neutral
MACD trend
Negative
Bearish
52-week position
89%
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $93 › 200d $81 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +173 funds added
Insider flow
Distributing
Net -$1.7M over 90 days · 100% sells
Short interest
Rising
1.78% of float · ▲ +0.2% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,450 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $68
Now $97 · 89%
Range high $100
vs 200-day avg +18%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Total segment adjusted earnings non-GAAP | $1.73B | Three Months Ended June 30, 2026 filing | — |
| Adjusted book value per share non-GAAP | $57.71 | Q2 2026 | — |
|
|
|||
| Adjusted earnings non-GAAP | $1.57B | 2Q26 | +15.5% |
|
|
|||
| Adjusted earnings available to common shareholders per diluted common share non-GAAP | $2.43 | For the Three Months Ended June 30, 2026 | — |
| Adjusted earnings available to common shareholders, excluding total notable items, per diluted c non-GAAP | $2.43 | For the Three Months Ended June 30, 2026 | — |
| Adjusted earnings available to common shareholders, on a constant currency basis non-GAAP | $1.57B | June 30, 2026 | — |
| Adjusted earnings per share non-GAAP | $2.43 | Q2 2026 | +20.3% |
|
|
|||
| Adjusted EPS growth non-GAAP | 20% | 2Q26 | — |
| Adjusted other expenses, on a constant currency basis non-GAAP | $3.66B | June 30, 2026 | — |
| Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT) non-GAAP | $13.01B | Q2 2026 | — |
|
|
|||
| Adjusted premiums, fees and other revenues, excluding PRT, on a constant currency basis non-GAAP | 13.01B | For the Three Months Ended June 30, 2026 | — |
| Adjusted premiums, fees and other revenues, on a constant currency basis non-GAAP | $13.52B | June 30, 2026 | — |
| Adjusted ROE, excluding total notable items non-GAAP | 17% | Q2 2026 | — |
|
|
|||
| Asia general account assets under management (at amortized cost) | $141.21B | Q2 2026 | — |
|
|
|||
| Common stock dividends | $400M | 2Q26 | — |
| Direct Expense Ratio non-GAAP | 12.1% | 2Q26 | — |
|
|
|||
| Direct expense ratio, excluding total notable items related to direct expenses and PRT non-GAAP | 12.1% | Q2 2026 | — |
|
|
|||
| Ending Institutional Client AUM | $320.46B | June 30, 2026 | — |
| Holding Company Cash | $3.9B | 2Q26 | — |
| Holding company cash and liquid assets | $3.4B | Q2 2026 | — |
|
|
|||
| Institutional Client Assets Under Management | 320.5B | Q2 2026 | — |
| MIM GA AUM | $427.67B | June 30, 2026 | — |
| Share repurchases | $700M | 2Q26 | — |
| Total assets under management | $748.13B | Q2 2026 | — |
|
|
|||
| Total cash return to shareholders | $1.1B | 2Q26 | — |
| U.S. Statutory Adjusted Capital non-GAAP | $16.4B | 2Q26 | — |
| Variable Investment Income Assets non-GAAP | 18.1B | For the Three Months Ended June 30, 2026 | — |
| Adjusted earnings per share, excluding total notable items non-GAAP | $2.42 | Three Months Ended March 31, 2026 | — |
| Adjusted expense ratio, excluding total notable items related to adjusted other expenses and PRT non-GAAP | 20.3% | Three Months Ended March 31, 2026 | — |
| Adjusted premiums, fees and other revenues non-GAAP | $1.74B | Q1 2026 | — |
| Asia GA AUM non-GAAP | $128.98B | Q1 2026 | — |
| Cash and Cash Equivalents and Short-term Investments Yield | 4.04% | March 31, 2026 | — |
| Ending Carrying Value | $455.73B | March 31, 2026 | — |
| Institutional Client AUM | $313.16B | March 31, 2026 | — |
| Insurance | $125.2B | March 31, 2026 | — |
| Intermediary (including Sub-Advisory) | $61B | March 31, 2026 | — |
| Investment income yield | 5.03% | March 31, 2026 | — |
| Net Investment Income Yield non-GAAP | 4.86% | March 31, 2026 | — |
| Operating margin non-GAAP | 19.7% | Q1 2026 | — |
| Other | $27.3B | March 31, 2026 | — |
| Pension | $87.8B | March 31, 2026 | — |
| Reinsurance AUM | 19.6B | March 31, 2026 | — |
| Separate Account AUM | 14.5B | March 31, 2026 | — |
| Sovereign Wealth Fund | $11.9B | March 31, 2026 | — |
| Third-Party AUM | 279.1B | March 31, 2026 | — |
| Total sales, on a constant currency basis non-GAAP | $370M | Q1 2026 | — |
| Variable investment income | $518M | Three Months Ended March 31, 2026 | — |
| Adjusted earnings available to common shareholders non-GAAP | $1.65B | December 31, 2025 | — |
| Adjusted expense ratio non-GAAP | 17.8% | FY2025 | — |
| Adjusted net investment income non-GAAP | $5.58B | Three Months Ended December 31, 2025 | — |
| Adjusted other expenses non-GAAP | $3.56B | December 31, 2025 | — |
| Adjusted other expenses, net of adjusted capitalization of DAC non-GAAP | $2.68B | December 31, 2025 | — |
| Adjusted PFOs non-GAAP | $7.21B | Three Months Ended December 31, 2025 | — |
| Adjusted PFOs, excluding PRT non-GAAP | $1.43B | Three Months Ended December 31, 2025 | — |
| Adjusted premiums, fees and other revenues, excluding PRT non-GAAP | $49.84B | FY25 | — |
| Adjusted return on common stockholders' equity non-GAAP | 17.6% | December 31, 2025 | — |
| Adjusted return on common stockholders' equity, excluding total notable items non-GAAP | 18.3% | December 31, 2025 | — |
| Adjusted return on MetLife, Inc.'s adjusted common stockholders' equity non-GAAP | 15.9% | FY2025 | — |
| Annualized general account spread | 1.24% | Q4 2025 | — |
| Annualized general account spread, excluding variable investment income yield | 0.99% | Q4 2025 | — |
| Average crediting rate | 4.34% | Q4 2025 | — |
| Average Loan-to-Value (LTV) Ratio | 68% | Q4 2025 | — |
| Average office LTV ratio | 80% | Q4 2025 | — |
| CML portfolio with DSCRs greater than or equal to 1x | 93% | Q4 2025 | — |
| CML portfolio with LTVs less than or equal to 80% | 77% | Q4 2025 | — |
| Commercial mortgage loans portfolio | $42.4B | December 31, 2025 | — |
| FCF Ratio non-GAAP | 81% | FY25 | — |
| Free cash flow of all holding companies non-GAAP | 4.9B | FY2025 | — |
| General account investment spread non-GAAP | 115 | FY25 | — |
| Group Life mortality ratio | 83.1% | FY25 | — |
| Group Non-Medical Health interest adjusted benefit ratio | 73.4% | FY25 | — |
| Institutional net flows non-GAAP | $5.61B | Three Months Ended December 31, 2025 | — |
| Interest adjusted benefit ratio | 72.2% | Q4 2025 | — |
| Investment income yield, excluding variable investment income yield | 5.1% | Q4 2025 | — |
| Japan Solvency Margin ratio | 770% | December 31, 2025 | — |
| MetLife Investment Management AUM by client segment - Insurance | $122.1B | December 31, 2025 | — |
| MetLife Investment Management AUM by client segment - Intermediary (including Sub-Advisory) | $65B | December 31, 2025 | — |
| MetLife Investment Management AUM by client segment - Other | $28.1B | December 31, 2025 | — |
| MetLife Investment Management AUM by client segment - Pension | $92.2B | December 31, 2025 | — |
| MetLife Investment Management AUM by client segment - Sovereign Wealth Fund | $11.9B | December 31, 2025 | — |
| MetLife, Inc. (parent company only) free cash flow non-GAAP | 3.7B | FY2025 | — |
| Mortality ratio | 81.1% | Q4 2025 | — |
| Net commercial mortgage loans | $42.4B | Q4 2025 | — |
| Ratio of free cash flow of all holding companies to consolidated adjusted earnings available to non-GAAP | 82% | FY2025 | — |
| Total adjusted earnings available to common shareholders non-GAAP | $1.65B | December 31, 2025 | — |
| Total average crediting rate | 4.11% | December 31, 2025 | — |
| Total investment income yield | 5.35% | December 31, 2025 | — |
| Total sales (Asia) | $598M | December 31, 2025 | — |
| Total sales (Latin America) | $451M | December 31, 2025 | — |
| Total sales, on a constant currency basis (EMEA) | $310M | December 31, 2025 | — |
| Total U.S. Statutory Adjusted Capital | $17.2B | December 31, 2025 | — |
| Variable investment income yield | 12.37% | Q4 2025 | — |
| VII Average Asset Balance | $18.9B | December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MET
this stock
Metlife Inc
|
$61.16B | +22.3% | +8.6% | 18.4 | 1.8% |
|
CILJF
China Life Insurance Co Ltd
|
$105.99B | +8.7% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$71.71B | +17.9% | — | — | 1.3% |
|
AFL
Aflac Inc
|
$58.42B | +5.7% | -9.3% | 12.6 | 2.2% |
|
GWLIF
Great-West Lifeco Inc.
|
$57.81B | +30.5% | — | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MET | +2.3% | +0.4% | +36.4% | +0.4% | +22.3% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +1.8% | -2.6% | +22.9% | -2.6% | +9.4% |
Capital returns
Latest dividend
$0.593
/ share · ex Aug 4, 2026
Paid (TTM)
$2.322
/ share · 4 payouts
Dividend yield (TTM, derived)
2.41%
Buyback program
· as of Aug 5, 2026
Authorized
$3.00B
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1099219
CUSIP
59156R108
13F (30d)
934 filings
874 filers
Visit website
Investor relations